ML-B01
ML-B01 is the orally active inhibitor for Akt and PKA with the IC50 of 2 nM and 136 nM. ML-B01 exhibits good ability to penetrate the blood-brain barrier (BBB) in the mouse brain[1].
Product Specifications
UNSPSC
12352005
Target
Akt; PKA
Related Pathways
PI3K/Akt/mTOR; Stem Cell/Wnt; TGF-beta/Smad
Field of Research
Cancer
Smiles
O=C(N1CCN(C2=C([C@H](C)C[C@H]3Cl)C3=NC=N2)CC1)[C@@H](C4=CC=C(Cl)C=C4)CNC(C)C
Molecular Formula
C24H31Cl2N5O
Molecular Weight
476.44
References & Citations
[1]Wu Y, et al., Pharmacodynamics of Akt drugs revealed by a kinase-modulated bioluminescent indicator. Nat Chem Biol. 2025 Feb 11.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
M2750-16A-ML650 100 µL
MCP3 (Macrophage/Monocyte Chemotactic Protein 3) (MaxLight 650) discontinued
Ask
View Details 
MBS7102400 Inquire
Recombinant Drosophila melanogaster Putative odorant receptor 49a (Or49a), partial
Ask
View Details